eSpCas9(1.1)_No_FLAG_ATP1A1_G2_Dual_sgRNA Citations (3)

Originally described in: Marker-free coselection for CRISPR-driven genome editing in human cells.
Agudelo D, Duringer A, Bozoyan L, Huard CC, Carter S, Loehr J, Synodinou D, Drouin M, Salsman J, Dellaire G, Laganiere J, Doyon Y Nat Methods. 2017 Apr 17. doi: 10.1038/nmeth.4265. PubMed Journal

---

Articles Citing eSpCas9(1.1)_No_FLAG_ATP1A1_G2_Dual_sgRNA

Articles
High-throughput assessment of mutations generated by genome editing in induced pluripotent stem cells by high-resolution melting analysis. Pham QT, Raad S, Mangahas CL, M'Callum MA, Raggi C, Paganelli M. Cytotherapy. 2020 Oct;22(10):536-542. doi: 10.1016/j.jcyt.2020.06.008. Epub 2020 Aug 4. PubMed
Activation of mitochondrial TRAP1 stimulates mitochondria-lysosome crosstalk and correction of lysosomal dysfunction. Chen FW, Davies JP, Calvo R, Chaudhari J, Dolios G, Taylor MK, Patnaik S, Dehdashti J, Mull R, Dranchack P, Wang A, Xu X, Hughes E, Southall N, Ferrer M, Wang R, Marugan JJ, Ioannou YA. iScience. 2022 Aug 14;25(9):104941. doi: 10.1016/j.isci.2022.104941. eCollection 2022 Sep 16. PubMed
Isocitrate dehydrogenase 1 sustains a hybrid cytoplasmic-mitochondrial tricarboxylic acid cycle that can be targeted for therapeutic purposes in prostate cancer. Gonthier K, Weidmann C, Berthiaume L, Jobin C, Lacouture A, Lafront C, Harvey M, Neveu B, Loehr J, Bergeron A, Fradet Y, Lacombe L, Riopel J, Latulippe E, Atallah C, Shum M, Lambert JP, Pouliot F, Pelletier M, Audet-Walsh E. Mol Oncol. 2023 Oct;17(10):2109-2125. doi: 10.1002/1878-0261.13441. Epub 2023 Jul 19. PubMed

If you have published an article using this material, please email us at to have your article added to this page.